Among these firms, only 1% say that they are very likely to begin covering GLP-1 agonists for weight loss within the next 12 months, 24% say that they were somewhat likely, 67% say that they were not likely, and 8% do not know the answer to the question [Figure 13.21]
2025 Jun;53:101890
Mindful eating : Learning to manage portions and develop healthier eating habits is key to sustaining weight loss
The idea is to avoid the common problem seen with GLP 1 weight loss drugs like Wegovy and Mounjaro, where many pic.twitter.com/0ICUH8FdLX Gandalv (@Microinteracti1) January 26, 2026 Biotech company Fractyl Health is preparing clinical trials of a gene therapy called Rejuva, which delivers genetic instructions directly to the pancreas
BMC Immunol (2017) 18:2
At the same time, sermorelin is ideal for patients seeking general growth hormone (GH) support, muscle growth, anti-aging benefits, and metabolic enhancement